biote Corp. Cash Flow Statement
BTMD|4 years of annual SEC 10-K data (FY2022-FY2025)
Covers operating cash flow, capital expenditures, free cash flow, share buybacks, and dividends paid across 4 fiscal years. All figures from audited SEC 10-K filings.
At a glance
Operating Cash Flow
$35M
FY2025
Free Cash Flow
$30M
FY2025
Capital Expenditures
$5M
Cash used for long-term assets
Dividends Paid
$2M
FY2025
biote Corp. generated $35M in operating cash flow and $30M in free cash flow in FY2025. Free cash flow margin was 15.7% of revenue.
Based on SEC 10-K filings.
Key Data Points
- Altman Z-Score NaN (distress zone, below 1.23 threshold)
- Negative shareholders equity: Liabilities exceed assets
- Cash-backed earnings: Operating cash flow exceeds net income
Data sourced from SEC EDGAR filings. Not investment advice.
| Item | FY2025 | FY2024 | FY2023 | FY2022 |
|---|---|---|---|---|
| Net Income | $27.0M | $3.2M | $3.3M | -$969.0K |
| Depreciation & Amortization | $3.7M | $3.6M | $3.0M | $2.2M |
| Operating Cash Flow | $35.2M | $45.2M | $26.9M | -$9.2M |
| Capital Expenditures | $5.0M | $6.4M | $359.0K | $333.0K |
| Free Cash Flow | $30.2M | $38.8M | $26.5M | -$9.5M |
| Share Buybacks | $3.4M | $5.6M | - | - |
| Dividends Paid | $1.7M | $4.7M | $8.7M | $12.9M |
| FCF Margin | 15.7% | 19.7% | 14.3% | -5.8% |